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the four cysteines conserved in other chemokines. SCM-1 also Abstract SCM-l/lympbotactin is a chemokine-like molecule 
produced selectively, if not exclusively, by activated CD8 + T carries a C-terminal sequence 20-30 amino acids longer than 
cells. Here we report that there are two highly homologous those of other chemokines. Its gene segregated with human 
SCM-1 genes, which we designate as SCM- la  and SCM-I[3. chromosome 1 in somatic hybrid cell lines [3]. Furthermore, 
Both genes have three exons and two introns. The 1st intron of SCM-1 was found to have a strong sequence similarity to a 
SCM- la  contains a pseudogene of the ribosomal large subunit newly described murine protein lymphotactin (60.5% identity 
L7a. In SCM-I[J, a 1.5-kb region including about a quarter of at the amino acid level) [4]. Lymphotactin was isolated from a 
the L7a pseudogene is deleted from the 1st intron. Otherwise, the murine pro-T cell cDNA library, found to be induced in 
two genes are highly homologous including the 5' and 3' flanking CD8 + T cells and CD4-CD8-  thymocytes upon mitogenic 
regions. Both genes were mapped to human chromosome lq23. stimulations, and shown to be chemotactic for lymphocytes 
The two genes were similarly induced in peripheral blood 
but not for monocytes or granulocytes [4]. Subsequently, the mononuclear cells by mitogenic stimulation. Primer extension 
and RNase protection revealed several transcription initiation human homologue of lymphotactin was isolated and identical 
sites. The biological activities of SCM- la  and SCM-I~, which to SCM-1 [5]. Human lymphotactin was shown to be pro- 
have two amino acid differences at positions 7 and 8 in the duced mainly by activated CD8 + T cells and to induce chem- 
mature proteins, remain to be compared, otactic responses and Ca 2+ flux in lymphocytes but not in 
monocytes [5]. 
Key words: Chemokine; Gene duplication; Chromosome As a first step toward gaining an understanding of molecu- 
mapping; Gene expression; Transcriptional initiation site lar mechanisms regulating the SCM-1 gene expression, we 
isolated genomic clones hybridizing with the SCM-1 cDNA. 
Unexpectedly, we found two highly homologous SCM-1 
1. Introduction genes. These genes, termed SCM-la and SCM-I[3, were 
both mapped to human chromosome lq23 and similarly in- 
The tissue accumulation of various leukocytes is a major duced in PBMC by mitogenic stimulation. 
sign of inflammatory responses. It is now known that struc- 
turally related 8-10-kDa heparin-binding polypeptides, collec- 2. Materials and methods 
tively called chemokines, are secreted from various types of 
cells upon proinflammatory stimulation and play roles in re- 2.1. Cells 
cruitment and activation of different subsets of leukocytes Various human lymphoid cell lines and HeLa were routinely main- 
[1,2]. Chemokines are currently divided into two subfamilies, tained in our laboratory [6]. PBMC were isolated from heparinized 
venous blood from healthy adult donors using Ficoll-Paque (Pharma- 
the CXC (or c0 and CC (or I~) ones, depending on whether cia, Uppsala, Sweden). Cells were stimulated with 1/100 PHA (Life 
the first two conserved cysteines in the mature peptide se- Technologies, Inc., Grand Island, NY), 50 ng/ml of PMA (Sigma, St. 
quences are separated by a single amino acid or adjacent. Louis, MO), or anti-CD3 antibody preadsorbed onto plastic dishes. 
The two subfamilies also differ in their target cell selectivity; 
the CXC chemokines are mainly chemotactic for neutrophils, 2.2. Blot analyses 
Southern blot analysis was carried out essentially as described pre- 
whereas the CC chemokines are mainly chemotactic for viously [7]. Briefly, genomic DNA was digested with indicated restric- 
monocytes and also for basophils, eosinophils, and lympho- tion enzymes, gel-fractionated, and blotted onto a Hybond N+ filter 
cytes with variable selectivity. The genes for the CXC chemo- membrane (Amersham Japan, Tokyo). Filters were prehybridized ina 
kines and those for the CC chemokines are separately clus- solution of 5xSSPE, 10xDenhardt's solution, 50% formamide, 2% 
SDS and 100 ~tg/ml of salmon sperm DNA at 42°C for 1 h and 
tered on human chromosome 4q21 q23 and 17qll-q21, hybridized overnight in the same buffer containing the SCM-I 
respectively [1,2]. cDNA labeled with [32P]dCTP using a Multiprime DNA Labeling 
Previously, we identified a novel secretory protein from a System (Amersham Japan). After washing at 60°C in 0.1 xSSC and 
library of human phytohemagglutinin (PHA)-stimulated per- 0.1% SDS, filters were subjected to autoradiography. Filters for hu- 
ipheral blood mononuclear cells (PBMC) by using an efficient man allele frequency determination were purchased from BIOS Lab- 
oratories (New Haven, CT). Northern blot analysis was carried out as 
signal sequence trap based on an Epstein-Barr Virus vector described previously [3]. 
[3]. The molecule, which we designated as single cysteine mo- 
tif- 1 (SCM-I), is significantly related to chemokines, especially 2.3. Isolation and sequencing ofthe genomic clones 
to the CC subfamily, but retains only the 2nd and the 4th of A human whole blood genomic library in Lambda Dash II was 
purchased from Stratagene (La Jolla, CA). About 106 plaques were 
prehybridized in a solution of 5 x SSC, 5 x Denhardt's solution, 50% 
*Corresponding author. Fax: (81) (6) 382 2598. formamide, 0.5% SDS and 100 I.tg/ml of salmon sperm DNA at 42°C 
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:~2P-labeled SCM-1 cDNA. After washing at 60°C in 0.1XSSC and sample (3 Ixg) was mixed with the probe (5x 10 '~' cpm) in 20 p.1 of 
0.1% SDS, plaques that were positive on duplicate filters were pur- hybridization buffer (80% formamide, 40 mM PIPES, pH 6.5, 400 
ified. Seven independent clones were isolated. Inserts were mapped by mM NaC1 and 1 mM EDTA), denatured at 90°C for 5 min, and 
digestion with restriction enzymes and hybridization with the SCM-1 incubated at 50°C for 18 h. Following hybridization, samples were 
cDNA. Two clones contained a 5.3-kb EcoRI fragment and five incubated with RNase A and RNase TI at 37°C for 40 rain. RNA was 
clones contained a 3.8-kb EcoRI fragment, both hybridizing with fractionated on a 6% polyacrylamide gel containing 8 M urea and 
the SCM-I cDNA. The 5.3-kb EcoRI fragment from clone hg40 detected by autoradiography. 
and the 3.8-kb EcoR1 fragment from clone hg44 were subcloned 
into pBluescript II (Stratagene), and sequential deletions were gener- 
ated using Deletion kit (Takara Shuzo, Kyoto, Japan). Nucleotide 3. Results and discussion 
sequences were determined using AutoRead Sequencing kit and 
A.L.F. DNA Sequencer (Pharmacia). The exons, exon-intron junc- 3.1. Cloning and genornic organization of two SCM- I  genes 
tions, 5' flanking sequences, and 3' flanking sequences were deter- We screened a human whole blood genomic l ibrary with the 
mined on both strands. SCM-I  cDNA and isolated seven independent positive clones. 
2.4. Chromosomal in situ hybridization Two clones contained a 5.3-kb EcoRI fragment and five 
This was carried out essentially as described previously [8]. The 5.3- clones contained a 3.8-kb EcoRl fragment. The entire nucleo- 
kb EeoRI fragment containing the SCM-la gene and the 3.8-kb tide sequences of a clone hg40 containing the 5.3-kb EcoRI 
EcoRI fragment containing the SCM-I[J gene were labeled using bio- 
tin-16-dUTP and Nick Translation kit (Boehringer Mannheim), com- fragment and a clone hg44 containing the 3.8-kb EcoRI frag- 
bined with sheared human DNA, and hybridized to bromodeoxyuri- rnent were determined. Each clone was found to contain a 
dine-substituted human metaphase chromosomes derived from PHA- complete SCM-I  gene. The SCM-1 gene in the 5.3-kb EcoRI 
stimulated PBMC. Biotin-labeled DNA was detected by fluorescein fragment which corresponded to the reported SCM-I  cDNA 
isothiocyanate (FITC)-conjugated avidin (5 lag/ml). Chromosomal 
identification was done by simultaneous staining with 4,6-diamidino- [3] was named the SCM- la  gene. The other gene, present in 
2-phenylindole (DAPI) and propidium iodide (PI), which produced the 3.8-kb EcoRI fragment, was named the SCM- I~ gene. We 
characteristic low contrast G-like patterns and high contrast R-like consider the SCM- I~ gene also functional because its coding 
patterns, respectively. The hybridizing loci were determined by the regions have no base changes generating stop codons or frame 
FITC and PI images, shifts, and the coding regions match exactly to a minor species 
2.5. Reverse transcription-polymerase chain reaction of lymphotactin cDNA that had been presumed to encode an 
To detect ranscripts from the two SCM-1 genes, reverse transcrip- allelic form of lymphotactin [5]. 
tion-polymerase chain reaction (RT-PCR) [9] was carried out using The organization of the two SCM-I genes is depicted sche- 
Superscript PreAmplification System (Gibco-BRL, Gaithersburg, matically in Fig. 1, and the entire nucleotide sequences are 
MD). First strand cDNAs were synthesized from 0.5 lag of mRNA 
using oligo(dT) primer. PCR was carried out by 35 cycles of dena- presented in Fig. 2. Both genes are composed of three exons 
turation at 94°C for 1 min, annealing at 55°C for 1 min and extension interrupted by two introns located at the same positions. The 
at 72°C for 2 rain. In order to normalize cDNA templates, amples sequences ot" the exon-intron junctions conform to the con- 
in 10-fold dilutions were first amplified with primers for glyceralde- sensus sequences of the eukaryotic splice junctions [10]. The 
hyde-3-phosphate dehydrogenase (GAPDH) (+5'-AGTCAGCCG- 
CATCTTCTTTGC-3' and -5'-CTCCTGGAAGATGGTGATGG- two genes are highly homologous except for the 1.5-kb se- 
GA-3'). Subsequently, normalized cDNA templates were amplified quence present only in the 1st intron of the SCM-lc~ gene 
using primers complementary to both of the SCM-I nucleotide se- (indicated by lower-case letters in Fig. 2A). Computer  analysis 
quences (+5'-TCAGCCATGAGACTTCTC-3' and -5'-TAATTT- revealed that the 1st intron of the SCM-Io~ gene contains an 
TATTCATGCAGTGCTYTCATA-3'). After amplification, PCR insert of 889 bp showing 83% homology to the coding se- 
products were purified using a PCR Prep kit (Promega, Madison, 
WI) and electrophoresed on a 2'/,, GTG agarose gel containing ethi- quence of the L7a/Surf-3 gene which encodes the ribosomal 
dium bromide either directly or after digestion with PmaCI (Takara large subunit L7a (Figs. 1 and 2A) [11,12]. This L7a sequence, 
Shuzo). PCR was also carried out using a sense primer specific for the being oriented in the opposite direction, is obviously a pseu- 
SCM-Icz nucleotide sequence (+5'-GGGAGTGAAGTCTCAGA- dogene with multiple in frame stop codons. It is known that 
TAA-3') or the SCM-I[J nucleotide sequence (+5'-GGGAGT- multiple copies of  the L7a pseudogenes exist in various mam- 
GAAGTCTCACATAG-3') and an antisense primer common to 
both the SCM-1a and SCM-I[J nucleotide sequences ( ee above), malian genomes [11,12]. In the SCM-I[J gene, a 1.5-kb frag- 
2.6. Mapping q[ transcriptional initiation sites 
Primer extension analysis was carried out as described previously SCM-I(~ Gene 
[7]. In brief, an oligonucleotide primer (5'-CCTTCCACAATGTATG- H R S 
CAGTGAGAGAGCAGATGCC-3'), which was complementary to 1 I ~ 1 L7A H R 
both SCM-Ic~ and SCM-I[J mRNA, was labeled at the 5' end with 
[y-:~2P]ATP using T4 polynucleotide kinase (Takara Shuzo). Poly(A) + exonl exon2 exon3 
RNA samples were prepared from Hut78, Jurkat and BALL-l, all 
stimulated with PHA+PMA for 24 h. Each RNA sample (3 lag) was SCM-1!3 Gene 
annealed with the labeled primer and incubated with Superscript I1 
reverse transcriptase (Gibco-BRL). The extension products were elec- H R H R 
trophoresed on a 6% denaturing polyacrylamide gel along with se- I I ~ , !1[] I 
quencing products generated using the same primer, xonl ~ / /  exon2 exon3 
RNase protection was also carried out essentially as described pre- e 
viously [7]. In brief, a 228 bp fragment of the SCM-Iot gene including 
the 154 bp upstream of the translation initiation site was amplified by H: Hindlll 500bp 
R: EcoRI PCR using primers +5'-TTAAGAAAAATAAAAGC-3' and --5'- deletion S: Sacl 
CCTTCCACAATGTATGCAGTGAGAGAGCAGATGCC-3', and 
subcloned into the pCRII vector (lnvitrogen, San Diego, CA). The Fig. 1. Schematic representation of the organization of the two 
construct was then linearized at the 5' end of the insert by XhoI, and SCM-1 genes. Shaded boxes represent coding regions, open boxes 
transcribed in vitro by the T7 promoter to generate 3~p-labeled anti- denote noncoding regions, and filled boxes correspond to the L7a 
sense RNA. Poly(A) + samples were prepared from Hut78, Jurkat and pseudogene sequence. The arrow indicates the orientation of the 
BALL-l. all stimulated for 24 h with PHA + PMA. Each RNA L7a pseudogene. 
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A -669 
AAGC~CTATAAATGTGTATG~AAGTTGT~tTAj~GCAK.~CACATGCATGTAGACATGC3-1~K~ACAG~ATTTKATTGTTT~TTGGGTACCTGGGGAGATGGGGTGK~GAAAGGGGGGT -550 
GAC TTGAAT CdLAG G TGGAGGAGJJULk4 TGAGAAC CK~Gk4~-GCAAAG A TC GAGAAGC TCAGT G T GGCAGCAGC TCTE TTE C ¢ C TC C TGAGA~ GTC~GGGTG G~ T EAG G~C TEA T -430 
GATCCATGGTTGTG~LAGCCTCATGT~LCACTGGATGTCACATCdLGGTGGGATGGAACACAGTGACCACCCCACCTCATTr  CTT ACAGCTTCCGTGG TGGGCCATGGCAGTCd~ACACC -310 
TrC~GGC~TGTCT~CGGCGG~T~T~TGAA~CAGG~TGGTGG~GG~C~ACAAC~CAkCC~GTTTTCTTTT~TGC~TGC~TTTGGTTT~A~C~C~T~AACC~C~GACAAAGGGGT~ -190 
AAGGCCACAAGGCG.~-rAGGTTAGTATGAACAGGC.AA~GGGACTT~u~TAAGAAAAAT` ~AAGCATCAGTATTGCAAAGACTTTC¢AT~ATCCTACA~CCACCTCGAAA~ -70 
CCCCCTCTCACCACAGGAAGTGCACT~CCACTGGAGGCATAA~GAGGTCCTCAAAGAGCCCGATCC1` ~TCTCC~GCACAGCTCA~CAGGACCTCA~(CATGAGACTTCTCATCC~ 51 
+Iv  N R L L I L  
GGCCCTC~GGCATCTGCTCTCTCACTG~ATACA~GTGGAAGGT--~GTGGA~GCTGT~TGTGAGATAAAGAACAGGGAGG~AAGG~AGGTGGG~ACACA~TTGGGT~GACTCAG 171 
A L L G I C S L T A Y I V E  
GTTATGACTGGACTAATCTGCTTT~CCCAGGGGAG~C~AAA~TTCCCATGTGCAAGAAAGGkATGATGATT~GA~TGTAGA~GGCTTCG~ULAC~CCA/d~ACA~GGA~kkTTTGA~ 291 
AGTATCTGGGcTCCTACTT~CCTAATTGGGTAATTTCAGGTA~CCTTAACCACTCAGGGCcTGTGCTTATTTATGTATAACT~A~TAGTAT~ACA~C~GATCACCTGAGATTKA 411 
GATTAAATAAATATTATGG~TATTTAATAACATCAGATTT~CTTA~AAG~AGTAATTTTTTGATTAATGTTAGCTATG~ATTAGAGGTGATGA~ATAAA~GCATTTGTA~GTTTT~C~ 531 
CATTTAATATAT?GTTTGATAAATTATCAAA~TCTTAGAGAGTTCAGTTACGATGTGGGGATGCACCATTGGATGTATGTTCTG6AGTAAATCAATG~TTTCAATAC~U~aa9cccc 651 
~a~t9~ct2g~gttc~a~¢cttcatgtcc~9~a~t¢~t~L~ccttc~gt~¢gtggggg~¢tctgtt~gt~at2ccaL9act~tt~ct~tt~tg~g~ttttctg~ttttgt~ 77~ 
9~g~c~ta¢~t~at~act~ct~c¢~ta~c~g~c~tta~c~c~gtt¢~c¢~c~gac~c~t~cag~t~ttc~ga~t~c~9~gccct t~cct~a~tt~t~ E91 
99tattt~tt~gg~ttgat~ttt¢¢~tg~¢tg~aggt9~etct~tc~¢Lt~ttt9Lg~t¢t~gttg9t~99ctt~ttectt~9~ct~tg~tett~t~ctt~t~t99~tcccca~ 1011 
9~99ttccat9~t~a~99t9~c~tct99~9t~Lt9~tL~t~Laa~a~a~aat~c~9~ac~aaa~tt9~tt~c~c~tta99c(~c~9~9ct~cctg~c 1131 
t99C~tt~t9¢t9~9a~t9g9c~t~cc~t~t~99~9~¢tc~9~t¢t9o9t~9g9~99~9ct¢~t~9tccco~t99tg¢tt~9cttc~toC~t~o~t9~999~c 9 1251 
gtctct9cttt9~t~o~tttt9~oc~t~a~t~aa~9tgat~tttt~t~a~a~act~a~att9ct9~c~t~9gaa~ctttgt9gttt¢a~gc~taa~a~tt 1371 
¢c¢~9~9tctt~9~agtc~acttc~ta¢ttc~ca~9~9~atatt9tt~¢tt~a~tat9~9a9~c~9~9~o¢cc~aLtttL¢ctctttc~tt9~ct~c~9~Ltc~ 1491 
~c~t~a~t~tt~9ca~a99t~9a~9ata9¢aaL9t9~a9~t99catt9a9~9t9~9~at9~t9~9~9~c~ca~tg~c~ctctttgttL~9LccctLg¢tLt~ 1611 
~L~cttct~Latt~c~cact~cc~a~gtt99cc~L~tca~t99ttacttta2~tgcttt~ta9cL~cct~tttcc~L9~9c~9~cc~9t9Lct~c~9cL~g9~g~ 1731 
aa~tca9~ctta9~act~99~tt~9~ttt¢ac~ca~¢ctta~ca9t~t~at~tc¢~a~9ttattttt~ctc~t9ca~t~ttttttt9~ttct~t~e~tt~tt~ttc~ 1851 
tt9~9ccatt~ct~Lt9~9g~L~c~t~ttta~999ct~ctt¢¢tttL~tatatatctLacctttt~ccattt~Lt~tLLttL~9~2ttLtt~Ltattttt~tgt~ca9~ctc~ I 1871 
~ca~t9t~cattt~cc~9~tt~t99c~a~t~c~t~t9ccttt9ctattt¢ca9ctt9~catt9t~ccac~9atttt~ctc9~c~ttg~9~ct~atc~t~tc~9tc~tt9~ 2091 
~t~t~tcct~ct~cc~cc~ctta9cc~cLcctt69tcttc¢t9~tt~acTTGTGT~AAGGCCACAGTGGTGCT~CCTGTG~ACTGGATGT~CCAGTCT~CC~C~AC~ I 2211 
~C~GATAA~GCATTAAGGGACCCCCCATTTTAG~CACAGGACAGACAGAAAGTTAACCAGCTTGATGGGGTCCACACCATGT~C/~TA~CAGCTGAGCCTTCTTCTTT7CCAGCAAGG~ 2331 
rGGTGATAGTGTTAACCCCTGCTCAAAGAACAGGTGATTTCCTAGTGGGGACAACCCCTTTGCTAGCAGCT~T~TTCTCAGCCTGGGCCAACAGTCTCTGC~C~CTC~GCTTTGTC~ n 2451 
~TGGTCAGTAC~GTGGATCAGCTTAAGTGG~TC~GTAGCTGTTTGGGGGTCTAAGGCTTGGGTGAACTGGTTK~TGGCAGAAGGCACTTTCAGCTGCTTATA~GGATAGcTCTTT~CA 2571 
;CTGGAACCAGATATAGCGGGGCCATTTCAC~kAGCAGCGGAGGTCCCT~GGGCTGGATGTCCTGTCCAATGCCTGCCTAAGAbU~CTCTTAGGCCTTTTCTCACACAGCGG~T~AT 2691 
~ACTTTCTTAGCCT~T~TT~T~AC~AC~CAGGGTCTGG~GCcACTTTCCTTCCTTTGGCCATCTTTCCTTTCAQ~AT~TTAQGCAGCTGACAGAGAG~GA~T~GAC~A~TKAA 2811 
AAG~AGAACAC~TTTATTTAGTCTGTCAAAA~cATGCTTCCTTCCCTCACTGAATGTT~CTTGCCTAGAGTACTCTTCACGCATTACTCTGTC~CTCACTAT~GTACTGTAACATG~ 2931 
GCACTATT~GAAATGATCTTTTCTGTTTGCCTGTCTGCTGCCTGGCTCCTrCATGAGAGAGATATGCTCTATGAAAACAGGAGTAATGTCTGCTTAGTAKA~CATGTG~GACAC~ACAGG 3051 
CACCATTGTATAAATGAATG~TGCGTGTCACTGGGGCATTTGCTAGCCGTCCCAJ~tTGTCTAAGTGAA~tTATACACA~GACGGG~TAACATCTIGTTATTrFCTCTcAGCATGAAAT 3171 
TC~TGAAACAATT~GTTGATTGAGTTTTTAAATTAGT~AAATAT~A~TAAGAATCTGTGACGGG~AAGAGATT~GGGATGCCTATCAGTCCT~TT~CC~CAAAAAGCAA~TGGCCT 3291 
TA~ATTCTCACAACAT~ C`TCAGAGTAATTTAACAGATGATTGT~CCTGTGATCTGGATAATTGCTTTAT~TTTAATTGTCTG3-rG~I~CCTCACCA.GGTGTA~GGAGTG~TC 3411 
GVGSEV 
TCAGATAA~AGGACCTGTGTGAGCCTCACTACCC~GCGACTGC~GTTAGCAGA~` TCAAGACCTAC~CCATCAC~GAAGGCTCC1~.GAGAGCAGTAAT~TGA~TCTGCCTCCT~AGA~T 3531
5 D K R T C V S L T T Q R L P V 5 R I K T Y T I T E G S L R A V I  
TGTGCTGGGTG~GTATCTAGAAGTATAGAAATACA~TCTGTAGAAATGCTGCCGTCCTCAGGKAAAGTAGGTCAGCATAGAGGAACACCTCAACTTAACCK~CCTCTTTAG~13.CC 3651 
TTATCAATCATGTCT~CTGCA~CCCAACCG~TAGCGATTATTGCAGAAATTGGGCTGCCA~GKAAGk~T~GAAGTCCTCCTCTATTTAGCTTAGTGG~GAGTCTG~G`~TACTGT 3771 
~CACAGCTCTGAGACCTG~GTTTAGAGkTGACTGGCCCATGTCAGGGTTTCCCTGC~AGCCTCACTG~A~TT~GGGGATCTTAGGGT~` GAGTCAGGCAGAGTCCCATACTTTTATCA~ 3891 
GCCATATTTCAAGAAAATGAGTCAATGCAC~CCT&CATG~TCCCTTCTTCTACCAGAA~CT~ATTTTTAGAAGTT~ATkACTCTTCTCAACATGTAATTGCAAGC.~TTACTCTAAAAAA 4011 
TGAAAAT~TA.~UUtATCACTTTTTATTTAAAKa.ATAAGATGAATATTTTrAAATTTGAA~GC` AAGAGG~ATGTAATAATGGAACTAGTrGGCCTCAAAGTC~G~AC~CA~G 4131 
GTGACATGGATGAGK~AAGGACCCTG~GK&TTATTGTGAACAAAGGGGCTGGATACTACT~GCAGATATTACTCC~TATGTTAAAATAGATGGCAGAAGAAGGGTACTCATTTATGATC 4251 
TCATGGCTCTGAAAGACTATTTCTTGCAGTAATTTCTGCACK~GATCTC~CATGTCTGCCCTGATCTTAACTCCTGACCCTGAGGCTrTGAGAATGTGGCTAACTTCGTCTGTCTTTTC 4371 
CTTGCGTTACA-GTTTTATTACCAAACGTGGCCT~AGTCTGTGCT6ATCCACAAGCCACATGGGTGAGAGACGTGGTCA6GAGCATGGACAGGAb~TCCAACACCAGAJ~TAACATGAT 4491 
F ~ T K R G L K V C A D P Q A T W V R D V V R S M D R K S N T R N N M ]  
CCAGACCAAG~CAACAGGAACCCAGCAATCGA~CAATACAGCTGTGACTCTGACTGGCTAGTAGTCT6TGGCAC~CTGTCCGT~TCCAGCCAGCCAG~TCATTTCACTTTACACGCTCAT 4611 
Q T K P T G T Q Q S T N T A V T L T G  ° 
GGACTGAGTTTATACTCACCTTTTATGAAAGCACTGCAT6AATAAA A~ATTCCTTTGTATTTT~ACTTTTAAATGTC~CTGTAT[CACTTATATG'I~CTKATTAATA~k ATTTA 4731 
TTATTAAGAATAGTTCCCTAGTCTATTCATTATATTTAGGGAAAGGTAGTGTATCATTGTT~TTTGATTTCTGACCTTGTACCTCTC1-(TGATGGTAACCATAATGGAAGAGATTCTGGC 4851 
TAGTGTCTATCAGAGGTGAAAGCTATATCAATCTCTC~AGAGTCCAGCTTGTAATGG~CTTTAC~CATCAGTCACK&G~ACAGCTGTGACAATGGCkACAATTTGAGATGTATTTCA 4971 
ACTTGTCTCTATAA7AGAATTC 4993 
J~ -667 
AAG~TATAAATGTGTATGTTAAGT~GTAATAK~G~AAA~A~ATGCATGTAAGA~ATGCTTAAA~AG~ATTTAATTGTTTC~GGGTA~TGGGGAGATGGGGT~LkGAAAGGGGGG ~548 
TGA~TTGAATGA~AGGTGGAGG~GAAk6ATGAGAACCAAGA~GCAAAGGATCGkGAAGCTCAGTGTGGC~GcAGCCTCTCTT~CCCTCCTGAGAGA~TCA~AGGGTGGCATCAGGGA(~ -428 
A7GATCCATGGTTGTGG~G~CTCATGTCACACTGGATGTCACATGAGGTGGGATGG~d~CACAGTGACCACCCCACCTCATTTC~TTTACAGC~rCCGTGGGGGC~TGGCAGTGAAC~G -308 
CCTTCAGGCATGTCTACGGTGGAAGATCTGKATTCAGGCTGGTGGCAGGAGACAACACK&CCACGTTTTCTTTTATGCATGCATTTGGTTTK&TTGACACA~AACCACAGACK~GGGG -188 
TA~AGG~CACAAGG~GATAGGTTAGTATGAACAGGGAA&G6GACATT~TTTAAGAAAAA~AK~AGCATC~GTA~GCAAAGACTTTCCATGA~CT~TAC~CACCTCGAAAGCC -68 
CCCTCTCACCACAGGAAGT6CACTGACCATTGGAGGCATAAAAGAGATCCTCA.~GAGCCCGATCC TCTCCCTGCACAGCTCAGCGGGACCTCAGCCATGAGACTTCTCATCCTGG 
H R L L I L  93 
CCCTCC~GG~ATCTGCTCTCT~ACT~CATACATTGTGGAAGGTAAGTGGAGA~GCTGTCTGTGAGATA~GAA7AGGGAGGCAAGG~AGGTGGGCACACATTTTGGGTTTGACTCGGGT 173 
A L L G I C S L T A Y I V E  
TTTGACTGGACTAAACTGCTGTCTCCAGGGGAGCCTTAAACTTCC~ATGTGCAbkGAAAGGA~TGATGATTTTGACTGTAGAGGGCTTCGTAAACTTCCAAAACA6GGAGA~TTTGA~A6 293 
TATCTGGGCTCCTACTTTT~CTAATTGGGTAATTTcAGGTk~kTTCCTTAACCACTcAGGGCCTGTGCTTATTTATGTATAAAcTGAATAGAAT~a` GAGACATC~TCACCTGAGATTAAG 413 
AT7A~TAAATATTATGGTTTATTTAATAACA~CAC~ATTTCCTTACAAGCAGTAATTTTTTGATTA~ATG~AGCTATGGA1~-AC~GGTGA7GAT~AT/~kATGCATTTGTAGGTT~G C 653 
AT~TAATATATAGTTTGATAAATTATCAAAAT~TTAGAGAGTTCAGTTACAATATGGGGATGCACCAGAGGAT6TATG~CT~G~GCAsUtTCAATGTTTTCAATACAA~C~ 533 
~ GCGACAGTAGTGCTTGCIGTGGACTGGATGTCCCAGT6TTGCCTTCCTTCCCcTTGATAA7GCA~TAAGGGACCCCCATIITAGGACGCAGGACA6GCAGAAA~TAACCAGC~GATC 773 GGT~CACACCATGTGCk~TCA~TA~CAG~TGAGA~TTCTTGTTTTCCAG~kAGGTGGTGATGATGTTk~CC~CTGCT~AAAGKACAGGTGATTTCCTAGTGG6GACAACCCCTTTG~T~ 893 
~CAGCTTTCT7C~CAGCCTGGGCCAACAGTCTCTGCTTCTTCTCTTGCTTfGTCTCTGGTCAGTACTTGTGGAT~AG~TTAAGTGGCTGAGTAGCTGTTTGGGGGTCTAAGGC~GGGT~ 1013 
~G CTGGTTAATGGCAGJU~GGCATTTTCAGCTGCTTATAGAGGATAGCTCTTTGC&GCTGGAACCAGATA7AGCGGGGCCATTTCACAAAGCAGTGGAGGTCTCTT~.GGGCTGGATGTCC 1133 TCCAATGCCTGCCTAAGAAAACTCTTAGGCCTTTTCTCACACAGCGGTTTCATCACTTTCTTAGCCTCCTGCTTCCTCACGACGGCAGGGACTGGGCCACC~CTTTCCTTTGGCC~ 1253 
~TTTCTT7TCAGCATCTTAGGCAGCTGACAGAGAG6GA~TTTGACCATTTA~GGGGAACACCTTTATTTACTCAG7CAAAAGCATGCTTCCTTC~CTCACTGAATGTTGCCT7G~C 1373 
7AGAGTACTCTTCACG~ATTAcTCTGTCATCTCACT7ATGG~AC7GTAACATGTTGCACTA~TGAAATGATCTTTTCT~TTTGCCTG~CTGCTGCCTGGCTC~CTCA~GAGAAGA~ATG 1493 
CTCTATGAAAACAGGGATAATGTCTGTC~AATAMU~CATGTGGGACACAACAGGCACCA~6TATAAAT~AATG~U~TGCGTGTCACTGGGGCATFTGCTAGCCGTCCCAAATGTCTA~G 1613
7GK~i~ATATA~ACAGAGACGGGATKACATCTTGTTATTT~CTCTCAGCATG~ATTCCTGA~CAATTCTGTTGATTGAGT~TTT~TTAGTCAAATATTTACT~GA~TCTGTG~CGG 1733 
~CAA6AGAT7CGGGATGCCTATCAGTC~TCTCTT~CCCC~GCAAATGGCCTTATA~CTCAC~ACA7TCTCAGAGTA~TTTA~CAGACGA~G~CCTGTGA7CTGGGT~TTGCT 1853 
TTATTTTTA~TTGTCTGT7GTTTTTTTTTCCTCATCA--GGTGTAGGGAGTGAAGTCTCACA7AG6AGGACCTG7GTGAGCCTCAC7ACCCAGCGACTGCCAGTTAGCAGk~TCAAGACCTA 1973 
G V G S E V S H R R T C V S L T T Q R L P V S R [ K T Y  
CACCATCACGG/~GGCTCCT7GAGAGCAGTAATG-~TGAGTCTGCCTCCTCAGAAGTT6GGCTGG6TGGGTACCTAGAGGTATAGAAA~ACACTCTATAGA/~` TGCT6CCA7CCTCAGGkkA 2093 
7 1 T E G S L R A V I  
AGTAGG~CAG~ATAGAGGAAC~CCTC/~CTTAACCAAAAACCTCTTTAGTTTTCCTTATCAACCATGTC~TC7G~AGCC~AA~CGAATAGCGATTA~GCAGA~ATTGGG~TGCCAAAG 2213 
AAAGAA7AGAAGTCCTCCTCTATTTGTCTTAGTGG` ~GAGTCTGTTGAATACTG7GCACAGCTCTGAGATCTGGGTTTAGAGATGGC~GGCTCATGTCAGGGTT~-CCCTGCAAGCCTCAC 2333 
T GGA'$~GGGGGATCTTAGGG~GAGTTAGGCAGAGTCCCATACTTTATCAGTTGCCATATTTCAAGA/~U~TGAGTCk~` TGCACAACCTACATGGTCCCTTTCTTCTACCAGAA7CTCAT 2453 
TTTT IGAAGTA~T~ACTCTTCCCAATACATATT6OU~GC TTTGC TCT/ckAGAATGAAAAT6TkA/U~ATCACCTTTTTAAAAAAAATAAGATGAGTATTTTCAAATTT~GG~GG 2573 
T TATATAATAATGGAACTAGATGGCCTCAAATGTC TTTTTGTTAC AA C ATTT6GTGACAT6GATGAGAAAAGGAGC  TGTGAATTATG6TGAACAAAGGGGCTGGATACTACTTGCAGAT 2693 
~TTTCTCCT~ATGTTAAA~TAGATGGCAGK~.GKAGGGTGCTCATTTA7GATCTCATGGCTCTGk~AGACTATTTC~GCAGTk4T7T~TGCACAAGATCTCTTCATGTCTGCC~TGATC 2813 
~4ACTCCTGACCCTGAGGCTTTGAGAACGTGGCTAACTTCATCTG7CTTTTCCTTGCGTTACAGTTTTATTACCK~CGTGGCCTAAAAGTCTGTGCTGATCCACAAGCCACG~GGGTG 2933 
- - F ~ T K R G L K V C A O P Q A T W V  
AGAGACGTGGTCAGGAGCATGGACAGGAAATCCAACACCAGAAA7AACATGATCCAGACCKAGCCAACAG6AACCCAG~TCGACCAATACAGCTGTGACCCTGACTGGCTAGTAGTCT 3053 
R O V V R S M D R K S N T R N N M I Q T K P T G T Q Q S T N T A V T L T G "  
~TGGCAC~CTGTCCGTCTCCAGCCAGCCAGC7CATTTCACTTTACACCCTCATGGACTGAGATTATACTCACCTTTTATGAAAGCACTGCATCAATKKAATTA~CTTTGTATTTTTA 3173 
CTTTTk/~TGTCTTCTGTATTCACTTATATGTTCTAATTAAT~AATTATTTATTAT~KAGAATAG~CCCTAGTCTATTCATTATATTTAGGGAAAGGTAGTG~ATCATTGTTGTTTGA 3293 
T~CTGACCTTGTACCTCTCT~GATGGTAACCATAATGGKAGAGATTCTGGCTAGTGTCTA7CAGAGGTGAAAGCTATATCGATCACTCTTAGAGTCCAGCTTGTAATGGTTCTTTACA 3413 
CATCAGTCACAAGTTACAGCTGTGACAATGGCKACAATTTGAGATCTAT~CAACTTGTCTCTATA'ATAGAATTC 34~8 
C ~ 
SCM-I~ : HRLLILALLGICSLTAYIVEGVGSEVsDKRT~V$LTTQRL~VsRIKTYTITEGSLRAVIFITKRGLKV~AD~QATwVRDwRSHDRKSNTRNNNIQTKpTGTQQSTNTAVTLTG 
SCM-I~: MRLLILALLGZCSLTAYZ~EGVGSEV~HRRTL~J~5LTTQRL~VSRIKTYTZTEGSLRAvIFZTKRGLKv~-jADpQATWVRDvvRSM~RKSNTRNNM~QTK~TGTQQSTNTAvTLTG 
inlron 1 intron 2 
ment including about 1/4 of the L7a pseudogene sequence is 97.5% homologous between the two genes. Similarly, the 0.4- 
deleted (Figs. 1 and 2B). The 0.7-kb 5' flanking sequences are kb 3' flanking sequences are 99% homologous between the 
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Fig. 2. Nucleotide sequences of the SCM-lce (A) and SCM-I[3 (B) genes. A major transcriptional start site at 34 bp upstream of the initiation 
codon is marked by an arrow and numbered as +1. The splice donor and acceptor sites are underlined. The putative polyadenylation signals 
are indicated by bold letters. The L7a pseudogene s quences are boxed. The 1.5-kb sequence in the first intron of the SCM-lc~ gene that is de- 
leted in the SCM-I[3 gene is indicated by lower-case letters. The nucleotide sequence data have been deposited in the DDBJ/EMBL/GenBank 
with accession umbers of D63790 for the SCM-lce gene and D63789 for the SCM-I[3 gene. (C) Alignment of amino acid sequences of SCM- 
Ice and SCM-1/3. Amino acid differences between SCM-lce and SCM-I/3 are indicated by asterisks. The two conserved cysteine residues are 
boxed. The cleavage site of leader sequences and positions of introns are indicated by an arrow and triangles, respectively. 
two genes with two typical polyadenylation signals same cDNA carried out FISH analysis and determined the 
(AAUAAAt  and one mRNA-destabil ization signal locus of its gene as lq23 [17]. This study, however, provided 
(UUAUUUAUU)  [13,14] immediately after the second poly- little information about the employed genomic probe. To re- 
adenylation signal, examine the locations of the two genes, we carried out FISH 
The positions of the exon/intron boundaries relative to the analysis using the 5.3- and 3.8-kb EcoRI genomic fragments 
protein sequences (Fig. 2C) are identical to the reported CC as probes. Using either probes, symmetrical double signals 
chemokine genes; the first exon encodes most of the leader were detected only on chromosome 1q23 and no other hybri- 
peptide, the first intron splits a codon between the first and 
second bases, and the second intron splits a codon for a hy- 
drophobic amino acid between the second and third codons A 
[15]. it is thus likely that the original SCM-1 gene arose from " _ 
- ~ ~ ~ ~:'r' ~= "*~ z~ the CC chemokine subfamily. Later, the insertion of an LTa ~ ~ ' 
pseudogene took place in the 1st intron of the original SCM-1 ~ ~. - ~ ,,, ,', w 
gene. This gene was then duplicated. Subsequently, the 1.5-kb ~kb~ 
region in the 1st intron containing a part of the L7a pseudo- - 23.~ 
- -  9 .4  
gene was deleted from one gene, resulting in SCM-I[3. _ 6.6 
The codmg regions of the SCM-Iot  and SCM-I[3 genes llO - 
44 
show 97% identity with only five nucleotide changes (Fig. ~!  " 
2A,B). The amino acid sequences deduced from the coding i:i~:i 
2.3  
sequences of the SCM- la  and SCM- I~ genes are identical - 2.0 
to each other except for two adjacent amino acids at positions 
28 and 29 (7 and 8 in the mature proteins): Asp-Lys in SCM- 
lc~ and His-Arg in SCM-I[8 (Fig. 2C). The cleavage sites for - 0.6 
the leader peptides of SCM-lc~ and SCM-I[8 are predicted to 
be between glycine and valine at amino acid positions 21 and 
22 (Fig. 2C) from their homologies to the processing sites of 
other chemokine proteins, from the rule of Von Heijne [16], 
and from the N-terminal amino acid sequencing of purified 
SCM-Ic~ secreted from Tn5B-4 insect cells infected with a B 
recombinant baculovirus (unpublished results). The calculated Afro-American Asian Caucasian 
molecular weights and pl  values of the mature protein are 
10271 and 11.10 for SCM-Ic< and 10321 and 11.69 for 
SC M- 1 !3. (kb) 
- -23 .1  
3.2. Southern blot analysis o /human genomic DNA with the 
SCM-1 eDNA - -  9.4 
Genomic DNA samples derived from various human cell 6.6 
lines were digested with EcoRI, electrophoresed, blotted onto --  4 4 
filters, and hybridized with the fulMength SCM-1 cDNA. As ~, . , ,  " ~ ~,~,m, , ,~ ~ o , ,  
shown in Fig. 3A, two EcoRl  bands with sizes of 5.3 and 3.8 
kb were hybridized with similar intensities in all the samples. 2.3 
The same two EcoRI bands were also seen with DNA samples 2.0 
from individuals with different racial backgrounds (Fig. 3B). 
These results indicate that the two highly homologous SCM-I 
sequences are indeed derived from independent genes and not 
due to an allelic polymorphism. 
- -  0 .~,  
3.3. Chromosomal localization qf  the SCM- lot  and SCM- I~ Fig. 3. Southern blot analysis of human genomic DNA demonstrat- 
genes ing the two SCM-I genes. (A) DNA samples (~20 p.g each) iso- 
Our previous segregation analysis of human-rodent somatic lated from various human cell lines and normal PBMC or (B) DNA 
cell hybrids for the SCM-1 gene using PCR demonstrated that samples (~ 8 btg each) from 19 individuals representing three differ- 
ent races were digested with EcoRI, gel-electrophoresed, blotted, 
the gene was located on human chromosome 1 [3]. By a simi- and hybridized with the fulMength SCM-I cDNA. After washing. 
lar hybrid segregation analysis, the same conclusion was re- bands were visualized by autoradiography. The size markers (kb) on 
ported for lymphotactin [5]. Another study also describing the the right were determined using a Hindlll digest of )v DNA. 
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A B analysis was incapable of distinguishing the SCM- la  and 
template ct p SCM-lf l  mRNAs because of their high sequence homology. 
I 456bp I SCM-lct primer a r~ a~'~ To determine separately the expression of the SCM-lot and 
I 230bp I 226bp I SCM-113 ~ SCM-lf l  genes, we carried out RT-PCR analysis [9]. The first 
one employed common primers for both SCM-lct and SCM- 
PmaCl ~ l f l  mRNA. The length of the amplified DNA was 456 bp for 
both mRNAs, but the products from each gene could be dis- 
tinguished by PmaCI digestion; only the SCM-lf l  gene con- 
,~ tains one PmaCI site and thus gives rise to 230- and 226-bp 
C PBMC Jurkat O .7 .7 fragments (Fig. 4A). The second one took advantage of the 
1 2 3 • o ~ two base differences in the first exon of these two genes; the 5' 
stimulalion ~ '~ ~r'~'~ --r~--~ ~ ~ II~ ~"~ '--+' primers were specific for either SCM- la  or SCM-lf l  mRNA 
and the Yprimer was common for both mRNAs. It was con- 
firmed that these primers were capable of amplifying the re- 
uncut spective SCM-1 genes without cross-amplification (Fig. 4B). 
cz+13~ ~ The primers for GAPDH were used for internal control. 
PBMC from three donors as well as Jurkat cells were cultured 
__ without or with mitogenic stimulation for 5 h and poly(A) + 
~ 1  r RNA samples were prepared. Using these RNA samples as 
templates, cDNAs were synthesized with oligo(dT) and am- 
plified by PCR. We obtained quite similar results by using the 
PmaCI two RT-PCR methods. 
~ ~ By the first method (Fig. 4C), we observed 456-bp amplifi- 
cation products in PBMC and Jurkat that were induced by 
mitogenic stimulations. By digestion with PmaCI, products 
I from SCM-Ict and SCM-1[3 mRNA were separately observed. 
Both genes were found to be induced upon stimulation. Low 
GAPDH levels of expression i  unstimulated PBMC samples appeared 
,,,,,~ . . . . .  ~ to be mostly from the SCM-lf l  gene. In Jurkat cells, both 
genes showed low levels of basal expression. By the second 
method (Fig. 4D), the specific primers for SCM-lct and those 
for SCM-I~ amplified respective bands that were induced in 
"~ PBMC and Jurkat upon mitogenic stimulations. Low levels of 
. . . . . . . .  expression were seen especially for the SCM-lf l  gene in un- 
stimulated PBMC samples. Both genes were also expressed at 
Fig. 4. RT-PCR analysis for expression of the SCM-la and SCM- low levels in unstimulated Jurkat. RT-PCR for GAPDH con- 
lfl mRNA. (A) Predicted length of restriction fragments digested firmed similar amounts of mRNA in all the samples. Collec- 
with PmaCI after PCR amplification with common primers for both tively, these results indicated that both the SCM- la  and 
the SCM-lc~ and SCM-I[J sequences (method 1). Because of their 
almost identical sizes, the 230- and 226-bp PmaCI fragments were  SCM-lf l  genes are inducible by mitogenic stimulation. 
hardly separated on the gel. (B) Specific amplification of the SCM- Furthermore, low levels of basal expression are often seen 
la  and SCM-lfl genomic sequences by a sense primer specific for especially from the SCM-lf l  gene. 
SCM-la or SCM-lfl and a common antisense primer (method 2). 
(C) Method 1. Poly(A) + RNA samples were prepared from PBMC 
(three individuals) timulated without (-) or with (+) PHA + PMA 3.5. Mapping the transcription initiation sites 
for 24 h and from Jurkat T cell line stimulated without (-) or with In order to determine the transcriptional initiation sites of 
(+) PHA for 24 h. RNA was reverse-transcribed using oligo(dT) the SCM-1 genes, we first examined various human leukemic 
and resultant eDNA was amplified with common primers for SCM- cell lines [6] for expression of the SCM-1 genes by Northern 
la  and SCM-lfl. Amplification products without or with PmaCl di- 
gestion were fractionated on a 2% GTG agarose gel. Fragments spe- 
cific for SCM-lct and SCM-II~ are indicated by arrows. Samples A B Jun~t 
(~t  exp) [ - - ]  
were also amplified with primers for GAPDH as internal control. ~E,v~-^u_ 0eM EI~I..L-1 ~ did HUT'/II I'OT'/13 ~1~ 
Size markers are ~X174 DNA digested with HinclI. (D) Method 2. , . . , , . . , , . . , , . . , . . , , . . , . . , , . . , .=M~,  ~ =,. 
The same RNA templates were amplified by RT-PCR using specific ' ~ ~' 
primers for SCM-lct or SCM-lfl. Size markers are ~X174 DNA di- ~ sc, u-~ seM-~ : 
gested with HinclI. ~ ~ "~ ........ 
dizing signals were detected (data not shown). We, therefore, Fig, 5. Northern blot analysis of SCM-1 mRNA expressed in var- 
conclude that the two genes are closely located in the q23 ious human lymphoid cell lines. (A) Poly(A) + RNA samples were 
region of human chromosome 1. prepared from indicated cell lines stimulated without (-) or with 
(+) PHA+PMA for 24 h. (B) Poly(A) ÷ RNA samples were prepared 
3.4. Detection of  the SCM-lt~ and SCM-I~ transcripts from Jurkat stimulated without (-) or with immobilized anti-CD3 
or PHA for 24 h. RNA samples (2 gg/lane) were fractionated on a 
Previous studies using Northern blot analysis howed that 1% agarose gel containing formaldehyde, blotted onto a filter mem- 
the SCM-1/lymphotactin gene was strongly induced upon mi- brane, and hybridized with 3ep-labeled SCM-1 eDNA. The same ill- 
togenic stimulations in PBL [3,5,17]. However, Northern blot ters were rehybridized with a probe for GAPDH as internal control. 
I 
II 
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A ~ ~ blot analysis (Fig. 5A). Hut78, a CD4 ~ T cell line derived 
< from Sezary syndrome, demonstrated a high level of constitu- D z 
ACGT "1- m ~ tive expression, which was further upregulated by PHA stim- 
~GGC~I ulation. No other cell lines showed such constitutive expres- 
sion. PHA treatment strongly induced the SCM-1 expression 
in two T-cell acute lymphoblastic leukemia (T-ALL) cell lines, 
Jurkat (CD4 ~) and PEER (CD4-/CD8-), but not in three 
other T-ALL cell lines, JM (CD4UCD8-), HPB-ALL 
(CD4+/CD8 +) and CEM (CD4+), or a B-ALL cell line, 
BALL-1. In .lurkat, we also found that the SCM-1 genes 
T were inducible by immobilized anti-CD3 which is supposed 
A G to mimic antigenic stimulation (Fig. 5B). In the case of murine 
G lymphoid cells, CD8 + T cells as well as CD4 CD8 thymo- 
A 
G cytes were shown to express lymphotactin upon activation [4]• 
1" Furthermore, human CD4+NKI.I + T cells were mentioned to G 
i / I be an important source of lymphotactin [5]. Thus, inducibility 
of the SCM-1 genes in some but not all T-ALL cell lines may 
GA~J i correlate with such specificity for T cell subsets• No human T- 
ALL cell lines singly positive for CD8 were, however, avail- 
able for testing. 
,~t~ To map the transcription i itiation sites of the SCM-lee and 
SCM-lj~ genes, we carried out primer extension analysis as 
well as RNase protection assay using poly(A)+ RNA prepared 
from Hut78, Jurkat and BALL-l, all stimulated with PHA+P- 
B MA for 24 h. The extension primer was complementary to 
~_ ~  "7 both the SCM- Ia  and SCM- I~ mRNAs. As shown in Fig. 
-r ~ m < ACGT 6A, several extension products were detected strongly in 
Hut78 and weakly in Jurkat. These extension products 
!~! mapped to 33, 34, 37 and 38 bp upstream of the ATG trans- 
lational start site. RNase protection assay essentially con- 
firmed the results of primer extension analysis, even though 
the lengths of protected RNA fragments could not be accu- 
~ rately determined (Fig. 6B). The major initiation site, the cy- 
m tosine at 34 bp upstream of the initiation codon (indicated as 
+1 in Fig. 2), matches to the cap consensus site [18], 5'-CA(C/ 
T)(C/T)(C/T)-3'. A probable TATA box (TAAAA) but no 
apparent CCAAT box is found in the upstream regions. 
In conclusion, we have demonstrated that there are two 
highly homologous genes encoding the SCM-1 proteins in 
the human genome. The two SCM-1 genes will be useful for 
elucidating the molecular mechanism of their regulated ex- 
pression in CD8~ T cells. The two SCM-I proteins have 
~ two amino acid differences at positions 7 and 8 in the mature 
proteins. The importance of the N-terminal regions has been 
:~ demonstrated for biologic activities of chemokines such as a 
6 ~ CXC chemokine Ik-8 [19,20] and a CC chemokine MCP-I 
i ~ [21]. Therefore, the two SCM-I proteins may have some dif- 
ferences in their biologic activities. Production of recombinant 
Fig. 6. Determination of the transcription initiation sites of the SCM-I¢~ and SCM-I[3, now in progress, will help us examine 
SCM-I genes. (A) Primer extension analysis. Hut78, Jurkat and their respective functions and identify their specific receptors. 
BALL-1 were stimulated with PHA+PMA for 24 h and poly(A) + 
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